VC firm
Bios Partners
Also known as Bios, Bios 2024 Co Invest, Bios 2024 Co-Invest, LP, Bios 2026 Co Invest, Bios 2026 Co-Invest, LP, BIOS Actuate Co Invest, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP
- Investor type
- VC
- Investing status
- Activeas of 2026-09-21Source (opens in a new tab)
- Headquarters
- Fort Worth, Texas, United States
- Assets under management
- $454MForm ADV private fund GAV, as of 2026-03-30Source (opens in a new tab)
- Latest fund size
- $48MSEC amount sold, as of 2019Source (opens in a new tab)
- Funds
- 33
- Legal name
- Bios Partners
Claim, correct or request removal
Record updated 29 September 2026
About
Bios Partners is a venture capital firm identifying advanced biotech in overlooked and under-invested markets in the U.S., which our team helps cultivate and bring to market.
Investment approach
- Thesis
- Bios identified a dearth of venture funding in the Central United States, where an abundance of innovative science is being continually developed. For example, there is a void in VC funding outside of Silicon Valley and the Northeastern US, where the NIH (National Institute of Health) funds $3.36 per every $1 of venture capital in the Central US. Compare this to $0.57 in the Western US and $0.68 in the Northeastern US of NIH funding for every $1 of VC funding. Given that the NIH is an unbiased source of funding and validation of technology, we believe this dynamic demonstrates the abundance of underfunded biotechnology in the Central U.S.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Currently, he serves on the board of Lantern Pharma, a New Jersey based clinical-staged precision oncology company.
- Investing status notes
- Whether you are looking to invest or seeking funds, feel free to email & we'll quickly be in touch.
Funds
- Bios 2026 Co-Invest, LP
- $3.4MVintage 2026, Main fund, SEC amount sold
- Bios i-Lumen Co-Invest I, LP
- $2.5MVintage 2025, Main fund, SEC amount sold
- Bios ONL Co-Invest II, LP
- $7.2MVintage 2024, Main fund, SEC amount sold
- Bios 2024 Co-Invest, LP
- $6.3MVintage 2024, Main fund, SEC amount sold
- Bios Clinical Opportunity Fund, LP
- $17.1MVintage 2023, Main fund, SEC amount sold
- Bios Special Opportunity Fund II, LP
- $7.4MVintage 2022, Main fund, SEC amount sold
- Bios Actuate Co-Invest III, LP
- $3.2MVintage 2022, Main fund, SEC amount sold
- BIOS SIRPant Co-Invest I, LP
- $5.5MVintage 2021, Main fund, SEC amount sold
- BIOS SIRPant Co-Invest I QP, LP
- $5.5MVintage 2021, Main fund, SEC amount sold
- BIOS ONL Co-Invest I, LP
- Vintage 2020Main fund
- BIOS Actuate Co-Invest II, LP
- Vintage 2020Main fund
- BIOS Fund III QP, LP
- $48MVintage 2019, Main fund, SEC amount sold
- More funds
- 21 more recorded
SEC registration
- Registered adviser
- BIOS CAPITAL MANAGEMENT, LP
- CRD number
- 298955 (opens in a new tab)
- SEC file number
- 801-117544
- Registration
- SEC registered
- Regulatory AUM
- $251Mas of 2026-03-30
- Private funds reported
- 24
- Principal office
- FORT WORTH, TX, United States
- SEC CIK
- 1640167, 1643749, 1659581
Locations
- Headquarters
- Fort Worth, TX, United States
Loading relationship preview